Managers / Q4 2022 · view latest →
ASSET PLANNING CORPORATION
CIK 0000007773 · 238 S. PETERS RD, BLDG A, KNOXVILLE, TN, 37923 · 865-690-1231
Summary
Asset Planning Corporation reported $120M in U.S.-listed holdings across 38 positions for Q4 2022.
Its largest position, VTV, represents 19.4% of the portfolio.
Compared with Q3 2022, the fund opened 5 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 94.5% · $114M
- Common Stock · 4.6% · $6M
- REIT · 0.6% · $706,027
- Other · 0.2% · $285,288
Quarter-over-Quarter Changes full breakdown →
vs Q3 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| DIMENSIONAL ETF TRUST | NEW | +308.3K | 308.3K | +$15M | $15M |
| AMGNAMGEN INC | NEW | +1.2K | 1.2K | +$317,269 | $317,269 |
| ISHARES TR | NEW | +2.6K | 2.6K | +$243,130 | $243,130 |
| NSCNORFOLK SOUTHN CORP | NEW | +884 | 884 | +$217,835 | $217,835 |
| REGNREGENERON PHARMACEUTICALS | NEW | +280 | 280 | +$202,017 | $202,017 |
| VANGUARD CHARLOTTE FDS | SOLD OUT | −225.9K | 0 | −$11M | $0 |
| SCHWAB STRATEGIC TR | TRIMMED | −1.6K | 6.2K | −$78,142 | $303,858 |
| VANGUARD INDEX FDS | TRIMMED | −2.7K | 11.8K | −$189,540 | $971,460 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | VTVVANGUARD INDEX FDS | SMALL CP ETF · VALUE ETF · S&P 500 ETF SHS · TOTAL STK MKT · REAL ESTATE ETF | 19.39% | $23M | 133.3K |
| 2 | DFARDIMENSIONAL ETF TRUST | NATL MUN BD ETF · US REAL ESTATE E · US MKTWIDE VALUE · US SMALL CAP ETF | 18.08% | $22M | 605.2K |
| 3 | SCHWAB STRATEGIC TR | SHT TM US TRES · US DIVIDEND EQ · SCHWAB FDT US LG · INT-TRM U.S TRES | 16.15% | $19M | 345.8K |
| 4 | VANGUARD TAX-MANAGED FDS | VAN FTSE DEV MKT | 10.90% | $13M | 312.0K |
| 5 | VANGUARD SCOTTSDALE FDS | SHRT TRM CORP BD | 9.68% | $12M | 154.6K |
| 6 | VANGUARD WORLD FDS | HEALTH CAR ETF | 6.37% | $8M | 30.9K |
| 7 | ISHARES TR | MSCI EAFE ETF · CORE S&P500 ETF · IBNDS MAR23 ETF · CORE S&P SCP ETF | 6.08% | $7M | 77.4K |
| 8 | VANGUARD ADMIRAL FDS INC | SMLCP 600 VAL | 5.60% | $7M | 42.8K |
| 9 | BRK/BBERKSHIRE HATHAWAY INC DELhistory → | CL B NEW | 1.30% | $2M | 5.0K |
| 10 | SPDR SER TR | S&P 600 SMCP VAL | 0.92% | $1M | 15.0K |
| 11 | EXMOCEXXON MOBIL CORP | COM | 0.73% | $874,569 | 7.9K |
| 12 | SPDR S&P 500 ETF TR | TR UNIT | 0.65% | $786,523 | 2.1K |
| 13 | MSFTMICROSOFT CORP | COM | 0.64% | $774,350 | 3.2K |
| 14 | AAPLAPPLE INC | COM | 0.59% | $706,679 | 5.4K |
| 15 | OREALTY INCOME CORP | COM | 0.59% | $706,027 | 11.1K |
| 16 | VANGUARD SPECIALIZED FUNDS | DIV APP ETF | 0.36% | $428,214 | 2.8K |
| 17 | NUENUCOR CORP | COM | 0.34% | $408,499 | 3.1K |
| 18 | AMGNAMGEN INC | COM | 0.26% | $317,269 | 1.2K |
| 19 | KOCOCA COLA CO | COM | 0.23% | $281,156 | 4.4K |
| 20 | NORTHERN LTS FD TR IV | INSPIRE INTL ETF | 0.21% | $250,294 | 9.6K |
| 21 | HDHOME DEPOT INC | COM | 0.20% | $235,632 | 746 |
| 22 | ISHARES INC | MSCI GBL MIN VOL | 0.19% | $225,387 | 2.4K |
| 23 | MDYSPDR S&P MIDCAP 400 ETF TR | UTSER1 S&PDCRP | 0.19% | $222,868 | 503 |
| 24 | NSCNORFOLK SOUTHN CORP | COM | 0.18% | $217,835 | 884 |
| 25 | REGNREGENERON PHARMACEUTICALS | COM | 0.17% | $202,017 | 280 |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2025 | $211M | 48 | Nov 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $188M | 43 | Jul 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $170M | 43 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $160M | 42 | Jan 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $153M | 45 | Oct 21, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $134M | 39 | Jul 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $137M | 41 | Apr 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $129M | 41 | Jan 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $130M | 41 | Oct 16, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $132M | 41 | Jul 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $124M | 37 | Apr 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $120M | 38 | Jan 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $107M | 34 | Oct 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $115M | 34 | Jul 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $115M | 34 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $117M | 35 | Feb 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $108M | 31 | Nov 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $103M | 31 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $96M | 29 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $101M | 68 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.